Uridine monophosphate (UMP)
Uridine Monophosphate (UMP) · also known as Uridylic acid, UMP, 5'-UMP, Kennedy brain nutrient triad core
Uridine is one of the building blocks cells use to make RNA and membrane phospholipids, and uridine monophosphate (UMP) is often used as a supplement. Animal studies show uridine can affect cholinergic and dopamine-related markers, but UMP’s effects on human memory and on brain neurotransmitters have not been confirmed.
Clinical uses and human evidence
Peripheral neuropathy (numbness and tingling)
Mechanisms of action
Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)
In animal experiments at exposures above typical human supplement levels, dietary UMP can increase striatal acetylcholine content and release. This suggests it may indirectly affect the cholinergic system through phospholipid metabolism. Dose and species differences are large, and human effects are not established.
Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)
Some animal studies suggest uridine-related substances affect dopamine transmission in the striatum, and some of these results came from UMP combined with DHA. The direction of change in dopamine receptor density and its significance in humans are not established, so it cannot be concluded that UMP alone improves human motivation or receptor sensitivity.
Neurotrophic factor synthesis and TrkB/A receptor activation
Nucleotides such as UTP can activate P2Y2 receptors, and in cell studies this receptor interacts with NGF/TrkA signaling. But these cell results cannot be extrapolated directly to UMP. There is currently no direct evidence on how UMP relates to the TrkB pathway, or on whether oral UMP changes BDNF and NGF signaling in humans.